Background: ORTHO VISION Analyzer (Vision), is an immunohematology instrument using ID-MT gel card technology with digital image processing. It has a continuous, random sample access with STAT priority processing. The efficiency and ease of operation of Vision was evaluated at 5 medical centers.
Although the use of automated instruments has been widespread in the areas of chemistry and hematology in hospital laboratories, only recently, an increasing number of blood banks are embracing automation. [1] [2] [3] [4] [5] [6] [7] [8] [9] In a recent
College of American Pathologists (CAP) survey, approximately 45% of the participants use automated instruments for at least the typing and screening tests. 10 Automation allows the transfusion service to manage increased test volume without increasing the number of staff members performing those tests, leading to improved productivity. Automated pretransfusion testing reduces the chance for manual errors and yields a safer and more efficient transfusion practice. 1, 3, 9, 11 More consistent laboratory results are produced in the blood bank by decreasing the variable of the individual technologist performing the tests. Automation also decreases technical, interpretation, and transcription errors when it is integrated within a laboratory information system (LIS). 9, 11 This field application trial was performed to assess the performance of the new VISION diagnostic instrument (Ortho-Clinical Diagnostics). The objective of this trial was to evaluate the training, configuration, quality control (QC), and maintenance requirements for this instrument, along with the VISION provides continuous, random specimen access with STAT (from the Latin word statum, meaning "immediately") processing at any time and phase of ongoing testing. Specimen racks and tubes are available in multiple sizes, to accommodate adult and pediatric volumes. As many as 42 specimens can be loaded onto the instrument and batched. The system tracks how long each specimen or reagent is on the instrument and maintains suspension through agitation. The monitor uses touch-screen technology and is flexible in positioning, according to operator needs. The specimen bar code reader is approved for 4 standard symbologies, including ISBT 128.
The test menu consists of ABO and Rh typing, antibody screening, antibody identification, cross matching, direct antiglobulin and antigen testing, serial dilution for titration studies, and QC testing. Multiple images of the test reactions are captured and then analyzed for grading and reporting purposes.
The instrument has minimal physical requirements. The self-contained liquid resources and waste management within the instrument eliminates the need for external plumbing. 
Materials and Methods

Results
Training
Every site designated 1 or 2 key operators, and 3 of the 5 sites also assigned a general operator. The key and general operators received online training, which was followed by hands-on training. The key operators were trained by an OrthoClinical Diagnostics technical specialist. Once the key operator achieved proficiency in operating the VISION instrument, he or she provided hands-on training to the general operator. By using this "train the trainer" model, we evaluated the ease of learning by the key operator and the ease of teaching another technologist how to operate the instrument.
The key operator training included system setup and configuration, resource management, maintenance, QC, specimen processing, result reporting, and troubleshooting. The training of the general operator was focused on the daily operation of the analyzer and included resource management, maintenance, QC, specimen processing, and results reporting.
The training and the materials provided at the start of the study covered all aspects of operating the instrument, including the sequence of training. The contents of the operator manual were judged by our participants to be clear and self-explanatory. Also, videos and portable document format (PDFs) were judged to make instructions easy to understand and to execute. The touch screen mimics that of other laboratory analyzers; this feature allows generalists to train on the analyzer much more quickly. The help menu was judged by the participants to be clearly written and the online reference guide to be easy to follow.
Step-wise instructions on the touch screen monitor were judged by the cohort to be easy to follow, especially with the screen specific help provided on the instrument.
The training, online and in person, was comprehensive; participants judged it to be of high quality. These features made the hands-on training less time consuming. Also, our participants judged that the maintenance training material was well prepared and easy to follow.
At the end of their training, all key operators felt confident to train the general operators at their work sites. Also, general operators were proficient enough to operate the instrument by the end of their training.
Overall, the average ratings for key operator and for general operator training were 4.3 and 4.5, respectively ( Table 1) . One key operator gave a lower rating on the evaluation questionnaire, to indicate that the training instructions could be improved.
System Configuration
The VISION analyzer allows site-specific configuration of itself. Different areas, such as testing, results, interfaces, maintenance, and user defined reports, can be configured by users. Key operators worked with the technical specialist of the manufacturer at its facilities to perform system configuration for the specific need(s) of each transfusion service.
Key operators reported that the configuration of the VISION instrument was user friendly and that the touch screen application made the usage process simple. These individuals opined that the material presented on the screens of the instrument is intuitive and that the reference materials provided sufficient help, along with that of the field trainer, for them to learn efficiently. They further stated their belief that the configuration guide was easy to follow and that they had promptly achieved their expected outcomes.
Key and general operators told us that the validation guide for the VISION instruments is comprehensive and opined that it is a useful resource. Because the validation process is condensed, implementation time is minimized.
Quality Control
The VISION QC system manages QC for reagents, ID-MTS Gel cards, and the instrument. It prevents the use of reagents or cards that have not been run with the QC system and also alerts the operator before the QC and reagent materials expire on the instrument. The instrument monitors the expiration dates of all QC material. The QC system monitors reagent volume, and expiration, as well as gel card integrity. The inventory control feature of the VISION provides improved compliance with regulatory standards. The system allows the use of manufacturer-provided or userdefined QC specimens. If operators only use the OrthoClinical Diagnostics QC kit for all QC functions, no additional specimen preparation is required; the QC kit covers the different types of testing performed by transfusion services.
The users reported that the QC setup on the VISION instrument was easy and user friendly. One site used inhouse QC material; those users reported that the instrument provided easy setup and use for those materials. Overall, the average rating for the QC feature was 4.1 ( Table 1) .
Despite the benefits of the VISION instrument, we observed a drawback. Many QC failures were observed secondary to debris in the gel columns. As a result, an improvement to the QC system would be to allow for operators to edit QC grades when results are questionable, to eliminate unnecessary QC runs.
Maintenance
The evaluation of maintenance activities included daily, weekly, and monthly maintenance. The manufacturer provides a daily, weekly, monthly, and yearly maintenance log, which can be modified for site-specific use.
Routine maintenance of the VISION instrument is, in our opinion, straightforward and simple to complete. The instrument is set up to mimic a chemistry analyzer, which will help generalists who might rarely use this instrument to perform maintenance. We believe that the online maintenance wizard is extremely informative, with pictures that lead the operator through the steps. The operator is required to stay with the instrument to tab through each screen; this part of the process could be automated. One site noticed that if weekly maintenance is performed before daily maintenance, doing so will reduce the amount of saline used for these procedures.
Overall, the average rating for maintenance was 4.3 ( Table 1) . One recommendation that our testing group of users offer is to combine weekly maintenance software interaction steps to shorten the time required to complete this task.
System Operation
The VISION instrument has good throughput because it has 2 centrifuges to process specimens and it has the ability to run multiple test profiles simultaneously. It allows loading of specimens and reagents continuously, without delaying inprocess work. As many as 120 gel cards of any type may be loaded onto the analyzer. The system needs to take inventory only in areas that have been accessed on every initialization. STAT specimens can be processed immediately without delay because the instrument can prioritize by ensuring that STAT specimens are processed before resuming routine testing. Gel cards can be easily accessed for review without interrupting processing.
When the antibody screening results are positive, the VISION instrument can automatically switch to antibody identification. We believe that the ability to select panel cells is a valuable feature and can replace manual testing, improving efficiency. The flexibility of the system allows running 3 different panels on 1 specimen or on different specimens. It also allows the selection of a few cells from 3 different panels for a single specimen or for multiple ones.
The VISION is easy to operate, maintain, and is flexible in performing a variety of tests. The operation of the analyzer is improved by the touch screen, as well as by the alert light, which is designed to get the attention of the operator. The ability to obtain the results of the ABO/Rh test independently from the antibody screen is a useful feature, especially for STAT and trauma specimens. Only saline solution and (Figure 1) . This finding represents a 12% time reduction with the VISION instrument, compared with the ProVue, across all test profiles. Figure 2 shows a side-by-side comparison of the TATs with the 2 instruments. The data shown therein indicate that the VISION instrument performs with greater consistency than the ProVue.
Type and screen tests were performed on 381 specimens on both instruments. The mean (SD) TAT was 32.2 minutes (4.5) with the VISION instrument and 37.0 minutes (7.4) with the ProVue (Figure 3 ). ABO and Rh typing (forward and reverse) were performed on 61 specimens; the mean (SD) TAT was 27.5 (5.6) and 32.4 minutes (9.8) with the VISION and the ProVue instruments, respectively ( Figure 4) . Table 2 summarizes the TAT for these profiles at all sites. Antibody identification with panel cells was performed on 134 specimens on the VISION instrument. The mean (SD) TAT was 43.2 minutes (8.3) ( Figure 5 ).
Compared with the ProVue instrument, the VISION also has increased efficiency in RBC reagent usage from a waste perspective. In an additional study performed by 2 of the participating sites, 36 specimens were loaded onto the ProVue and the VISION instruments in 4 batches of 9 specimens, and type and screen tests were performed. The VISION instrument used 30% less RBC reagents than the ProVue. In a separate experiment, another 36 specimens each were loaded onto the ProVue and the VISION instruments, based on the arrival pattern of the specimens into the facility. A normal arrival pattern consisted of a random number of specimens loaded onto each analyzer when the specimens arrived at the blood bank. The 36 specimens were added to the instrument in 13 different time intervals. A single load of 5, 8, and 9 specimen each and 4 loads of 2 specimens and 6 loads of a single specimen were loaded on the instrument in a random order. The results from this testing schedule indicated that the VISION instrument used 57% less RBC reagent material, compared with the ProVue (Figure 6 ). The greatest difference in RBC usage was apparent between the VISION and ProVue instruments when testing was based on arrival pattern. This finding occurred due to the dead volume required for the pipetting process in the ProVue system. When specimens are run based on the arrival pattern, the ProVue instrument has a significantly higher dead volume of RBCs for each subsequent pipetting event. In contrast, the pipetting system of the VISION instrument minimizes the dead volume and therefore optimizes reagent RBC usage.
Although the participants in these field trials believed that the VISION is an efficient analyzer, it allows for only individual results to be archived at one time. A potential enhancement to the instrument, which could increase efficiency, would be to allow for multiple results to be archived simultaneously.
Serial Dilutions for Titrations
Serial dilution is an automated process with the VISION analyzer. The instrument has the capability of creating 10 dilution levels of each patient specimen, along with the undiluted specimen and a control specimen. The instrument performs the dilution series and reads the results in immediate spin (IS) and in antihuman globulin (AHG) phases without any technical assistance from a technologist. The automated antibody titers provide more reproducible results and will indicate more accurately if a true rise in titer has occurred. Our study participants reported believing that the dilution function is simple to set up, the contents of the reference material are self explanatory, and the online prompts are intuitive. In our opinion, this dilution function is a strong addition because it would decrease the subjectivity and variability found in titers, while saving technologists significant time, compared with the tube technique.
The reproducibility of titers with an automated method appeals to us; however, switching from the tube method to the more sensitive gel test will require establishing new critical values for clinical application. A comparative validation process is necessary to establish these new values. Like any change in critical values due to test-method changes, training of health care providers on the sensitivity of the new method and new critical values is required before the new method can be implemented.
Remote Result Review
The Remote Result Review is a feature of the VISION analyzer that we believe is innovative. Through its e-connectivity, the system configuration and performance information can be reviewed remotely to deal with any issues Figure 5 All panels from all participating sites in the study. before quality is affected. This feature would also allow a supervisor or an Ortho-Clinical Diagnostics representative to remotely log into the analyzer, troubleshoot problems, and download software updates. The system provides adequate permission levels and security.
This feature was evaluated at 2 sites during these field trials. Both sites found it highly useful, especially in a smaller blood bank staffed by generalists.
Analyzer Troubleshooting
If an error message appears, the error message will tell the operator exactly what steps to take next. The within-analyzer reference library provides the same information as the reference guide. Our study participants reported that when the reference documentation was insufficient, the customer service hotline was a helpful resource.
The screen specific help feature made it easy to troubleshoot problems as they arose, as our participants reported. Econnectivity significantly improved troubleshooting ability in our participant sites.
Conclusions
Every site participating in these field trials reported a highly positive experience using the VISION analyzer. The installation, operator training, configuration, maintenance, and validation processes are simplified and streamlined, to yield short implementation time. The QC program of the VISION instrument provides compliance with CAP regulations because new reagents or card lots are restricted until the required QC testing is performed.
Also, our users reported their belief that the inventory control capability of the VISION system is strong. The efficiency of the VISION instrument can be improved by the continuous loading of reagents and specimens, by STAT processing without delay, by separating ABO/Rh reporting from antibody screening result, and by the ability to review cassettes without interrupting the testing process. The VISION instrument has shorter TAT, compared with the ProVue. The operator handson time is reduced by accommodating neonatal and pediatric specimens, by automatic reflex to antibody identification, and by the automated dilution test.
The ability to select test cells and the serial dilution functionality are other useful additions. VISION requires less reagent material and RBCs for testing, and only uses saline solution and deionized water, leading to more cost-effective operation. We believe that the bidirectional interface and bar coding capability reduce transcription errors and improve productivity, leading to safer transfusion practices. The remote result review feature helps with troubleshooting of issues, by supervisors from a distance or by an OrthoClinical Diagnostics technical specialist. Opportunities for improvement of the VISION instrument that were identified during these field trials were in the areas of editing QC results, shortening maintenance steps, and flexible archiving and printing options. We believe that a few features of the VISION analyzer, as described in this article, will be welcomed by generalists because the changes mentioned herein have made operation of the VISION analyzer similar to that of chemistry analyzers.
Overall, we found that the VISION instrument fully meets the needs of our laboratory operations. We believe that the testing was easy to set up and run, and that the TATs were excellent. The average TAT for all test profiles was approximately 4 minutes faster on the VISION analyzer vs the ProVue. The ability to run multiple test profiles simultaneously is also a great advantage, in our opinion. Another major advantage we perceive in the VISION instrument, compared with the ProVue, is the ability of the VISION to continuously load reagents and specimens without disrupting testing, as well as the ability to process STAT specimens immediately without delay. Further, automation of serial dilution on the VISION analyzer would also greatly improve efficiency. LM
